Grossi C E, Ciccone E, Tacchetti C, Santoro G, Anastasi G
Department of Experimental Medicine, Human Anatomy Section, University of Genova, Italy.
Ital J Anat Embryol. 2000 Oct-Dec;105(4):97-124.
In the introductory section of this report, the anatomy of the immune system, from organs and tissues to molecules, will be reviewed briefly. Cell proliferation and differentiation in the central lymphoid organs (thymus and bone marrow) yield a repertoire of T- and B-cell clones that seed into peripheral lymphoid organs (spleen, lymph nodes and Mucosa-Associated Lymphoid Tissue, MALT), where humoral and cell-mediated antigen-specific immune responses occur. The stringent process of clonal selection in the central lymphoid organs implies deletion of inappropriate cells via apoptosis. In the peripheral lymphoid organs, the potential of unlimited activation and expansion of lymphocytes in response to antigens is primarily regulated by apoptosis and anergy. These events, on the one hand, are relevant to prevent autoimmunity and lymphoproliferative disorders; on the other hand, clonal deletion and anergy provide a detrimental escape to immune recognition of malignant cells. Two major inhibitory mechanisms of the immune response have emerged recently. One is linked to the existence of bona fide suppressor cells and cytokines; the other relies on the existence of inhibitory molecules expressed by T, B and NK cells, as well as by other leukocytes. In the studies herein reported, emphasis will be given to surface membrane molecules that down-regulate T-cell-mediated immune responses. These molecules control interactions between T cells and antigen presenting cells (APC's) or target (virus-infected or mutated) cells that have to be killed. Two sets of molecules exist that either upregulate (coactivation molecules) or down-regulate (inhibitory molecules) T-cell mediated responses. The latter aspect of the immune regulation, i.e. molecules that limit the expansion of T-cell clones following specific recognition of antigens will be considered in depth. Two inhibitory molecules, CD152 (CTLA-4) and CD85/LIR-1/ILT2 are expressed in all T cells, being largely confined within intracellular compartments of these lymphocytes when they are in a resting state, but ready to be shuttled to and from the plasma membrane when cells are activated following encounter with antigen. Membrane expression of the two inhibitory molecules is transient and is regulated by an internalization process directed to endosomal compartments and to receptor degradation and/or recycling. CTLA-4 and CD85/LIR-1/ILT2 play a pivotal role in T-cell homeostasis that follows any cell-mediated immune response; their localization and functional role will be thoroughly analyzed. In the last part of this study a major question will be faced, i.e. is the containment of the possibly unlimited expansion of the immune system due to a blockade of the cell cycle? Or, else, could be apoptosis the sole mechanism responsible? Experimental data in support of the latter contention will be provided.
在本报告的引言部分,将简要回顾免疫系统的解剖结构,从器官和组织到分子层面。中枢淋巴器官(胸腺和骨髓)中的细胞增殖和分化产生了一系列T细胞和B细胞克隆,这些克隆会迁移至外周淋巴器官(脾脏、淋巴结和黏膜相关淋巴组织,即MALT),在那里发生体液免疫和细胞介导的抗原特异性免疫反应。中枢淋巴器官中严格的克隆选择过程意味着通过凋亡清除不适当的细胞。在外周淋巴器官中,淋巴细胞对抗原作出反应时无限激活和扩增的潜能主要受凋亡和无反应性调节。一方面,这些事件与预防自身免疫和淋巴增殖性疾病相关;另一方面,克隆清除和无反应性为恶性细胞的免疫识别提供了有害的逃逸途径。最近出现了两种主要的免疫反应抑制机制。一种与真正的抑制细胞和细胞因子的存在有关;另一种依赖于T细胞、B细胞、NK细胞以及其他白细胞表达的抑制性分子的存在。在本文报道的研究中,将重点关注下调T细胞介导的免疫反应的表面膜分子。这些分子控制T细胞与抗原呈递细胞(APC)或必须被杀伤的靶细胞(病毒感染或突变细胞)之间的相互作用。存在两组分子,一组上调(共激活分子)而另一组下调(抑制性分子)T细胞介导的反应。免疫调节的后一个方面,即限制T细胞克隆在特异性识别抗原后扩增的分子,将进行深入探讨。两种抑制性分子,CD152(CTLA - 4)和CD85/LIR - 1/ILT2在所有T细胞中均有表达,当它们处于静止状态时,主要局限于这些淋巴细胞的细胞内区室,但在细胞与抗原相遇后被激活时,随时准备穿梭于质膜内外。这两种抑制性分子的膜表达是短暂的,并且受导向内体区室以及受体降解和/或再循环的内化过程调节。CTLA - 4和CD85/LIR - 1/ILT2在任何细胞介导的免疫反应后的T细胞稳态中起关键作用;将对它们的定位和功能作用进行全面分析。在本研究的最后部分,将面临一个主要问题,即免疫系统可能的无限扩增的遏制是由于细胞周期的阻断吗?或者,凋亡可能是唯一的负责机制吗?将提供支持后一种观点的实验数据。